冠状动脉状穿孔在慢性全闭塞重通道化期间得到有效管理:一个案例报告
Gao Haokao1, Chen Genrui1, Wang Huan1
1Department of Cardiology, the First Affiliated Hospital of Air Force Military Medical University, Xi'an, China.
概括
在慢性全封闭 - 穿皮冠状动脉干预 (CTO-PCI) 期间治疗冠状动脉穿孔的一种新技术包括用药物释放式支架 (DES) 密封状入口,从而减少对多个覆盖式支架 (CS) 的需求.
科学领域:
- 干预心脏病学 干预心脏病学
- 血管医学 血管医学
- 医疗器械技术 医疗器械技术
背景情况:
- 冠状动脉穿孔是慢性全封闭-穿皮冠状动脉干预 (CTO-PCI) 期间的一种严重并发症.
- 大型血管穿孔往往需要覆盖式支架 (CS) 植入,但多次CS部署可能并不总是解决问题.
- 了解穿孔机制对于开发有效解决方案至关重要.
研究的目的:
- 在CTO再通道化过程中,在左中前下降动脉 (LAD) 中呈现埃利斯II级穿孔病例.
- 为了证明一种替代策略来管理CS植入后的持续扩散.
- 强调识别和密封状穿孔入口的重要性.
主要方法:
- 在CTO重新道化过程中,LAD发生了Ellis II级穿孔.
- 在穿孔部位周围部署了三个CS,但外流仍然存在.
- 从远端左主干部 (LMT) 到近端LAD部署了一种药物排泄支架 (DES),以封闭状入口.
主要成果:
- 尽管在三个部署的CS中进行了后扩张,但持续的扩散仍然存在.
- 通过部署一个单一的DES.成功地封闭了状穿孔入口.
- 输出被有效地解决,证明了新方法的有效性.
结论:
- 准确识别状穿孔是成功管理的关键.
- 用DES封闭穿孔入口可以有效地解决外流.
- 这种方法可以减少对复杂穿孔的多个CS植入物的依赖.
更多相关视频
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
19.2K
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
9.0K
相关概念视频
01:17Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...